BCL10 Antikörper (FITC)
Kurzübersicht für BCL10 Antikörper (FITC) (ABIN2589964)
Target
Alle BCL10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Human BCL10 / BCL-10
-
Aufreinigung
- Caprylic acid and ammonium sulfate precipitation
-
Immunogen
-
Recombinant human B-cell lymphoma/leukemia 10 protein.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.03 % Proclin 300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Andere Bezeichnung
- BCL10 / BCL-10
-
Hintergrund
-
Name/Gene ID: BCL10
Family: Apoptosis
Synonyms: BCL10, Bcl-10, B-cell CLL/lymphoma 10, B-cell lymphoma/leukemia 10, CARMEN, CARD-like apoptotic protein, CCARMEN, C-E10, CIPER, Cellular-E10, HCLAP, Cellular homolog of vCARMEN, CLAP, ME10 -
Gen-ID
- 8915
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Target
-